Nacubactam

Generic Name: Nacubactam

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₉H_₁₆N_₄O_₇S

CAS Number: 1452458-86-4

Unique Ingredient Identifier: 832O37V7MZ

Background: Nacubactam is under investigation in clinical trial NCT03174795 (A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

Phase 1

Completed

Conditions: Gram-negative Bacterial Infections

Interventions: Drug: nacubactam
Drug: meropenem

First Posted Date: 2017-06-09

Last Posted Date: 2018-04-23

Lead Sponsor: Hoffmann-La Roche

Target Recruit Count: 21

Registration Number: NCT03182504

Locations: 🇺🇸
Pulmonary Associates Clinical Trials (PACT), Phoenix, Arizona, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy